RNS Number : 2576E
QinetiQ Group plc
02 July 2019
QinetiQ Group plc (the "Company")
Notification and public disclosure of transactions by persons discharging managerial responsibilities or persons closely associated with them
|
|
Vested Shares
|
Shares sold for Income Tax and expenses
|
Retained Shares
|
|
Steve Wadey
|
150,952
|
71,197
|
79,755
|
The Company makes this announcement, including the notification below, in accordance with the requirements of the EU Market Abuse Regulation.
|
1.
|
Details of PDMR / person closely associated with them ("PCA")
|
|
(a)
|
Name
|
Steve Wadey
|
|
2.
|
Reason for the notification
|
|
(a)
|
Position / status
|
Chief Executive Officer / Director
|
|
(b)
|
Initial notification / amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
(a)
|
Name
|
QinetiQ Group plc
|
|
(b)
|
Legal Entity Identifier Code
|
213800S8OBDOZMCMUW34
|
|
4.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
(a)
|
Description of the financial instrument
Identification code
|
QinetiQ Group plc ordinary shares of 1 pence
GB00B0WMWD03
|
|
(b)
|
Nature of the transaction
|
Vesting at 31.7% of the 2016 Performance Share plan and sale of sufficient shares in order to satisfy Income Tax and National Insurance Contributions required to be withheld on release.
|
|
(c)
|
Price(s) and volume(s)
|
Price(s) Volume(s)
Vesting Nil 150,952
Sale of Shares
To satisfy income
Tax and NICs liability £2.80 71,197
Transfer of Shares Nil 79,755
|
|
(d)
|
Aggregated information
- Price
- Volume
|
Vesting: Price Nil / Volume: 150,952
Tax/NI sale: Price £2.80 / Volume 71,197
Transfer: Price Nil / Volume 79,755
|
|
(e)
|
Date of the transaction
|
2019-07-01
|
|
(f)
|
Place of the transaction
|
London Stock Exchange XLON
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHSSFFIEFUSESW